Columbia Care Inc.

Q2 2023 revenue was $129.2 million, up 4% sequentially and flat versus Q2 2022. Adjusted gross profit was $52.2 million, up 9% sequentially and down 5% year over year, and adjusted gross margin was 40.4%, about 2 percentage points higher than Q1. Adjusted EBITDA was $20.3 million, up 24% sequentially and 69% year over year, with adjusted EBITDA margin at 15.7%, up 260 basis points sequentially. The company said income statement results will show a positive operating profit for the quarter. Cash ended the quarter at $37 million, with a $3 million overall cash burn, $1.7 million of gross CapEx, and negative $313,000 of cash flow from operations. Management expects positive cash flow from operations in Q4 2023 and said the next debt maturity is $5.6 million of convertible notes due in December 2023. It also said it is on track for $38 million in annualized cost savings, has commitments to exchange some 13% notes due in May 2024 into 9.5% notes due in 2026, and closed two new mortgages in early August grossing $8 million, with about $10 million of debt paid down from asset sale proceeds.

Nicholas Vita framed the quarter as evidence that Columbia Care is moving through an inflection point: improving margins, tightening operations, and leaning into the company’s strongest markets. He emphasized that most of the heavy capital spending is already behind them, so future growth should come more from using existing assets better than from large new builds. His tone was confident and upbeat, but he repeatedly stressed that the strategy is about long-term, sustainable gains rather than quick fixes.

Derek Watson focused on the improving financial profile and balance-sheet actions. He highlighted the $129.2 million of revenue, $52.2 million of adjusted gross profit, 40.4% adjusted gross margin, and $20.3 million of adjusted EBITDA, then tied the margin drag to underutilized cultivation sites that reduced gross margin by about 5 percentage points. He also detailed liquidity at $37 million in cash, the $3 million cash burn, the $1.7 million of gross CapEx, expected $38 million in annualized savings, the $5.6 million December 2023 debt maturity, the planned note exchange, and the $8 million of new mortgages and roughly $10 million of debt paydown.

Analysts focused on capital allocation, the timing of margin recovery from underutilized capacity, and growth in markets like Maryland, Virginia, Ohio, Florida, California, and Colorado. Management said it has enough existing cultivation and retail capacity to support growth and that the main priority is improving utilization, with the gross-margin drag from reduced canopy expected to unwind gradually rather than quickly. On Florida, management said it is a competitive, limited-priority market where the company will stay disciplined on capital; on Ohio, management said new dispensaries and eventual adult-use changes could help, but timing remains uncertain because of legislative risk.